Price versus volume
Can management show how much of revenue growth came from price, volume, mix and FX by major market?
Evidence library · Singapore · food and beverage manufacturing · information cut-off 21 September 2026
Food Empire makes and sells branded soluble coffee mixes and snacks through distributors, retailers and food-service channels across Russia, Southeast Asia, Central Asia, South Asia and Europe.
In 1H2026 revenue rose 15.0% to US$315.1m, but operating cash flow fell to US$26.1m while PP&E capex rose to US$30.1m and dividends used US$38.8m.
The central risk is that inventory, FX, capex and legal-entity funding may reduce the accessibility of reported group cash; the public evidence does not establish entity-level availability.
The next test is a price-volume-mix bridge, inventory ageing, REN and facility terms, and commissioning/utilisation evidence for new capacity.
The live questionCan branded coffee and snack growth keep converting into accessible cash after inventory, factory capex, dividends and debt movements?In 1H2026 revenue rose 15.0% to US$315.1m, but operating cash flow fell to US$26.1m while PP&E capex rose to US$30.1m and dividends used US$38.8m.
FY2025 revenue grew 21.1% to US$576.9m, normalised EBITDA reached US$113.5m and Russia, Southeast Asia and Central Asia all grew in the reported regional table.
1H2026 inventory was US$123.1m and trade receivables US$71.4m; group gross debt diagnostic was US$112.2m, while the public evidence set does not map unrestricted cash by legal entity.
The weaker half-year cash conversion may reflect timing around inventory, capex and dividends rather than weaker demand; the statements alone do not isolate recurring operating cash.
A price-volume-mix bridge, inventory ageing, legal-entity cash map, REN term sheet and facility schedule would show whether growth is self-funding.
Drawn from the evidence on this page: the improvement, the constraint, the benign reading and the fact that would settle it. It states no view on the shares.
The private research record contains the integrated equity and issuer-only credit work, model, source register and review status. Access is restricted.
Business anatomy · from inputs to customer value
Food Empire makes branded coffee mixes and snacks, then sells through distributors, retailers and food-service channels across a multi-region footprint.
Follow the operating chain from demand or inputs to customer outcome and cash.
Route to marketRoute to market
What happensCoffee mixes and snacks move through distributors, retailers and food-service channels.
Revenue triggerChannel reach and shelf availability turn factory output into sales.
End-market exposureRegional demand
What happensRussia, Southeast Asia, Central Asia, South Asia and Europe are the named 2025 revenue regions.
Demand driverGeographic mix spreads demand but leaves currency and concentration questions.
Company actionFactory capacity
What happensThe group has disclosed coffee-mix and snack capacity work in Kazakhstan, Malaysia, India and Vietnam, with milestones at different stages.
Value createdUtilisation and commissioning determine whether capex becomes volume and margin.
Cash conversionCash conversion
What happensOperating cash funds inventory, working capital, capex, dividends and debt movements.
Cash triggerCash conversion depends on stock, receivables, capex and funding access.
Investor translation
Four questions connect the business model to cash and balance-sheet risk. This is a factual reading aid, not a valuation or recommendation.
Food Empire reported higher revenue and operating profit in FY2025, while the 1H2026 interim statement shows continued top-line growth and a positive statutory profit after the prior-year fair-value loss related to REN.
| Line | FY2024 | FY2025 | 1H2025 | 1H2026 | Change |
|---|---|---|---|---|---|
| Revenue | 476.347 | 576.917 | 274.060 | 315.073 | +15.0% 1H |
| Gross profit | 144.392 | 193.518 | 90.170 | 103.978 | +15.3% 1H |
| Operating profit | 63.281 | 93.368 | 42.757 | 47.131 | +10.2% 1H |
| Profit / (loss) attributable to owners | 52.869 | 35.966 | (1.452) | 35.381 | prior-year fair-value effect |
| Normalised EBITDA | 78.275 | 113.475 | 52.215 | 58.831 | +12.7% 1H |
| Operating cash flow | — | 87.063 | 32.378 | 26.056 | reported |
Sources: FY2025 annual report, pp. 84–87 and 111–113; 1H2026 interim financial statements, PDF pp. 3 and 9. Normalised EBITDA is issuer-labelled and is not a statutory subtotal.
The FY2025 annual report describes growth as driven primarily by price gains and higher sales volumes. Russia was the largest named revenue region; Southeast Asia and Central Asia were the next two. The residual below is calculated as group revenue less the five named regional figures and is not an issuer-defined geography.
| Region | Revenue | Share | Issuer movement |
|---|---|---|---|
| Russia | 191.0 | 33.1% | +34.8% |
| Southeast Asia | 147.8 | 25.6% | +14.3% |
| Central Asia | 102.0 | 17.7% | +25.6% |
| South Asia | 71.0 | 12.3% | +15.7% |
| Europe | 48.6 | 8.4% | +7.6% |
| Other / residual | 16.517 | 2.9% | calculated, not assigned |
| Group revenue | 576.917 | 100.0% |
Source: FY2025 annual report, regional discussion and segment information. Shares and the residual are deterministic calculations from the filed figures. The filing does not provide an independent market-share measure in this evidence set.
Management disclosures point to a multi-year capacity programme. The useful follow-up is not the announcement alone, but whether each asset commissions on time, reaches utilisation and earns cash after working capital and maintenance needs.
| Location / asset | Disclosure | Timing stated by issuer | Evidence to watch |
|---|---|---|---|
| Kazakhstan coffee-mix facility | Construction completed; production commenced | Earlier in 2026 | Ramp, utilisation and cash cost |
| Malaysia snack factory expansion | Expansion completed | Completed in FY2025 | Post-completion utilisation and volume mix |
| India soluble coffee facility expansion | Existing facility expansion to increase capacity by about 60% | Targeted by end-2027 | Remaining capex, commissioning and utilisation |
| Vietnam freeze-dried coffee facility | New facility project | Projected by 2028 | Capex, approvals and utilisation |
Sources: FY2025 annual report; 1H2026 results release and results briefing. These are issuer-stated project descriptions and timing, not an independent forecast.
FY2025 operating cash flow was US$87.1m. After PP&E capex of US$22.2m, the reported cash-flow statement still shows dividends, debt repayments, debt proceeds and a placement as separate cash movements. In 1H2026, operating cash flow was US$26.1m and PP&E capex was US$30.1m in a period that also paid US$38.8m of dividends.
| Measure | FY2025 | 1H2026 | Reading |
|---|---|---|---|
| Cash and short-term deposits | 181.537 | 151.342 | filed balance-sheet line |
| Inventory | 126.686 | 123.070 | working-capital exposure |
| Trade receivables | 55.541 | 71.423 | collection exposure |
| Loans | 45.989 | 63.511 | current plus non-current |
| REN liability | 36.793 | 37.153 | terms not fully retrieved |
| Lease liabilities | 11.447 | 11.548 | current plus non-current |
| Group gross debt diagnostic | 94.229 | 112.212 | loans + REN + leases |
| Group net cash diagnostic | 87.308 | 39.130 | cash less diagnostic debt; does not measure parent-accessible cash |
Sources: FY2025 annual report cash-flow statement and balance sheet; 1H2026 interim financial statements, pp. 5 and 9. The group gross debt and net cash diagnostics are calculations, not issuer-defined credit metrics; entity-level restrictions, REN terms and facility covenants remain open.
FY2025 revenue grew 21.1% to US$576.9m. Operating cash flow was US$26.1m in 1H2026, and capital expenditure was US$30.1m. 1H2026 inventory was US$123.1m and trade receivables US$71.4m. The group gross debt diagnostic was US$112.2m in 1H2026.
Can management show how much of revenue growth came from price, volume, mix and FX by major market?
Which legal entities hold the cash, owe the debt and fund the capex, and what restrictions sit between them?
What commissioning and utilisation milestones will demonstrate that the new factories are earning their capital?
What are the settlement terms, maturity profile, collateral, covenants and refinancing sources behind the REN liability and borrowings?
Where the primary sources are filed. Food Empire investor relations home · Food Empire FY2025 annual report · Food Empire 1H2026 interim financial statements. Exchange portals re-file and purge documents over time; the text above cites each document by name and date so it can be found again. Tables on this page as data: JSON · CSV — the page’s own as-filed and recomputed tables, cell for cell, with their section and caption.
Information cutoff: 21 September 2026. Public content is factual evidence and transparent calculations from the cited sources. The private research record is separate and subject to its own review status.
Discuss public information and ideas with readers. Posts are independent reader discussion, not SMID Research coverage.
Find available event transcripts in the transcript library.
Forecasts, ratings and full initiation research are in the private research library.